To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

NCT02057250 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

RA

Interventions

DRUG: Sarilumab
DEVICE: Auto-Injector Device (AID)
DEVICE: Pre-filled Syringe (PFS)
DRUG: Methotrexate
DRUG: Sulfasalazine
DRUG: Leflunomide
DRUG: Hydroxychloroquine

Sponsor

Sanofi

Collaborators

[object Object]